These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12815967)

  • 1. [Insulin-like growth factor-1 receptor in tissues of the mollusk Anodonta cygnea ].
    Leĭbush BN; Chistiakova OV
    Zh Evol Biokhim Fiziol; 2003; 39(2):128-33. PubMed ID: 12815967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin-like peptides of cerebro-pleural ganglia of the mollusc Anodonta cygnea: isolation, purification and radioligand analysis].
    Rusakov IuI; Kolychev AP; Shipilov VN; Bondareva VM
    Zh Evol Biokhim Fiziol; 2003; 39(4):339-45. PubMed ID: 14520897
    [No Abstract]   [Full Text] [Related]  

  • 3. Pleiotropic action of insulin-like peptides of mollusk, Anodonta cygnea.
    Shipilov VN; Shpakov AO; Rusakov YI
    Ann N Y Acad Sci; 2005 Apr; 1040():464-5. PubMed ID: 15891090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and ligand-receptor analysis of insulin-related peptides from pedal ganglion of the mollusc Anodonta cygnea].
    Rusakov IuI; Kolychev AP; Shipilov VN; Bondareva VM
    Tsitologiia; 2004; 46(5):442-7. PubMed ID: 15344890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Streptozocin model of diabetes mellitus in the mollusc Anodonta cygnea: functional state of the adenylyl cyclase mechanisms of action of peptides of the insulin superfamily and their effect on carbohydrate metabolism enzymes].
    Kuznetsova LA; Plesneva SA; Chistiakova OV; Shpakov AO; Bondareva VM; Pertseva MN
    Zh Evol Biokhim Fiziol; 2007; 43(6):460-7. PubMed ID: 18265556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity modulation of human placental insulin and insulin-like growth factor receptors by lectins.
    Masnikosa R; Nikolić A; Nedić O
    J Biochem; 2008 Jun; 143(6):813-20. PubMed ID: 18316333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Binding of insulin-like growth factor I (IGF-1) in skeletal muscles of Lampetra fluviatilis dominates over insulin binding and increases during spawning migration].
    Leĭbush BN; Chistiakova OV; Guttierrez I
    Zh Evol Biokhim Fiziol; 2000; 36(6):552-7. PubMed ID: 11212533
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic and immunohistochemical localization of insulin-like growth factor-I receptor binding sites in brain of the brown trout, Salmo trutta.
    Smith A; Chan SJ; Gutiérrez J
    Gen Comp Endocrinol; 2005 May; 141(3):203-13. PubMed ID: 15804507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
    Johansson GS; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
    Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
    J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Certain biochemical characteristics of an insulin-like substance from the bivalve mollusk Anodonta cygnea].
    Rusakov IuN; Bondareva VM; Karasev VS; Leĭbush BN; Barkan RS; Pertseva MN
    Biokhimiia; 1991 Apr; 56(4):718-26. PubMed ID: 1912075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA; Rosenzweig SA
    Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
    Chisalita SI; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grb10 adapter protein as regulator of insulin-like growth factor receptor signaling.
    Morrione A
    J Cell Physiol; 2003 Dec; 197(3):307-11. PubMed ID: 14566960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone.
    McTavish H; Griffin RJ; Terai K; Dudek AZ
    Transl Res; 2009 Jun; 153(6):275-82. PubMed ID: 19446281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by insulin-like growth factor 1 in brain.
    Bondy CA; Cheng CM
    Eur J Pharmacol; 2004 Apr; 490(1-3):25-31. PubMed ID: 15094071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-I binding to the IGF-I receptor is affected by contaminants in commercial BSA: the contaminants are proteins with IGF-I binding properties.
    Slaaby R; Andersen AS; Brandt J
    Growth Horm IGF Res; 2008 Aug; 18(4):267-74. PubMed ID: 17945524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.